Brookstone Capital Management Reduces Stock Position in The Clorox Company (NYSE:CLX)

Brookstone Capital Management decreased its stake in shares of The Clorox Company (NYSE:CLX) by 91.7% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,484 shares of the company’s stock after selling 83,052 shares during the quarter. Brookstone Capital Management’s holdings in Clorox were worth $1,146,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its position in shares of Clorox by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 15,341,234 shares of the company’s stock valued at $2,010,622,000 after acquiring an additional 44,344 shares during the last quarter. Morgan Stanley boosted its holdings in Clorox by 1.8% in the 3rd quarter. Morgan Stanley now owns 1,738,928 shares of the company’s stock valued at $227,904,000 after purchasing an additional 30,902 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in shares of Clorox in the 4th quarter valued at approximately $144,844,000. Norges Bank acquired a new stake in shares of Clorox during the 4th quarter worth approximately $128,382,000. Finally, Parsifal Capital Management LP purchased a new stake in shares of Clorox during the 4th quarter valued at approximately $128,245,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. UBS Group lowered their price objective on Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. BNP Paribas started coverage on shares of Clorox in a report on Monday, June 24th. They issued an “underperform” rating and a $130.00 price objective on the stock. Wells Fargo & Company decreased their target price on shares of Clorox from $140.00 to $135.00 and set an “underweight” rating on the stock in a research report on Thursday, May 2nd. Morgan Stanley reiterated an “equal weight” rating and set a $160.00 price target on shares of Clorox in a research report on Tuesday, March 26th. Finally, DA Davidson reaffirmed a “neutral” rating and set a $162.00 price objective on shares of Clorox in a research report on Wednesday, April 17th. Five investment analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company’s stock. Based on data from MarketBeat, Clorox has a consensus rating of “Hold” and a consensus price target of $145.33.

Clorox Price Performance

Shares of NYSE CLX opened at $136.47 on Friday. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53. The company has a market cap of $16.95 billion, a price-to-earnings ratio of 70.71, a price-to-earnings-growth ratio of 2.19 and a beta of 0.39. The stock’s 50-day moving average is $136.95 and its two-hundred day moving average is $143.80. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.14.

Clorox (NYSE:CLX) last released its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same period in the prior year, the firm earned $1.51 earnings per share. The business’s quarterly revenue was down 5.3% compared to the same quarter last year. Analysts forecast that The Clorox Company will post 5.91 EPS for the current fiscal year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.